AB STRA CT The precipitate which resulted when 57CoB12 bound to normal human gastric juice was subjected to a 15% concentration of Na2SO4 contained virtually no radioactivity. However, after in vivo incubation of the gastric juice57CoB12 mixture in the distal ileum of the guinea pig, the dialyzed extract of the washed mucosa contained a fraction of 57CoBl2 which was precipitated at 15%o Na2SO4. In addition, in vitro incubation of gastric juice-57CoB12 with an extract of the ileal mucosa or brush border membranes also resulted in the formation of a 15%o Na2SO4-insoluble fraction which contained 57CoB12. The formation of this 57CoB12-containing insoluble fraction did not occur or was diminished by (a) addition of an excess of B12-free normal human gastric juice, (b) reducing the incubation pH to 2, (c) incubating the mixture at 4VC, (d) pretreating the ileal extract at 560C for 30 min, (e) incubating the reaction in sodium EDTA but not calcium EDTA, (f) incubating gastric juice57CoB12 with an extract of jejunal mucosa. Sephadex gel filtration was used to demonstrate that the factor in the ileal extract which reacted with the gastric juice-57CoB12 filtered through G-100 and G-200 columns in the excluded volume.
When the ileal extract obtained after in vivo incubation with gastric juice-57CoB12 was subjected to starch gel electrophoresis one peak of radioactivity remained at the origin and another moved anodally. Eluates of each peak reacted with anti-intrinsic factor antibody indicating that at least the immunologically reacting portion of the intrinsic factor molecule was present in two fractions with different electrophoretic mobility.
These studies indicate that immunologically intact intrinsic factor can be extracted from the ileum after in vivo incubation with gastric juice57CoB12, and that a macromolecular factor is present in the distal ileal mucosa which binds intrinsic factor both in vitro and in vivo, changing its solubility and electrophoretic properties. It is suggested that this ileal binding factor is the previously postulated intestinal receptor for intrinsic factor.
INTRODUCTION
The intestinal absorption of vitamin B12 is dependent on a complex series of events requiring, as Castle originally discovered (1) , the presence of a heat-labile factor in gastric juice, which has been designated intrinsic factor (IF). It has been established that IF binds (2) and then carries the B12 molecule to the ileum where, in man (3) and other animals (4, 5) absorption of the vitamin takes place.
More enigmatic is the specific mechanism which facilitates the passage of the large, water-soluble B12 molecule (mol wt 1365) through an intact mucosal cell. Indeed, the mystery of this absorptive process is compounded by the firm attachment of the vitamin to IF, a large carrier protein. It has been shown in man (6) and rat (4, 7) that the absorption of B12 is a time consuming process which is probably not energy dependent, for metabolic inhibitors have either no (8) or only a slight inhibitory effect (9) .
The role of IF in facilitating the absorption of B1.2 at the cellular level once it has transported the vitamin through the lumen of the small intestine has been the subject of many investigations. Although Strauss (19) . After washing the isolated membranes twice with 0.005 M EDTA and twice with Ringer'sbicarbonate, the preparation from a single ileum was resuspended with 2 g of glass beads in 2.5 ml of Ringer's-bicarbonate, subjected to mechanical disruption for 3 min, and the cellular particulate was then separated by centrifugation at 4°C (30,000 g).
The objective of the experiments to be described next is to show that gastric juice-bound '7CoB12 undergoes a change in solubility and electrophoretic properties after it is incubated either with intact or with extracts of ileal mucosa. The experiments also aim to demonstrate that such changes are due to an interaction between the IF-Bu, complex and a factor in the ileal mucosa.
The solubility of bound '7CoB,2 in labeled ileal extract at 15% Na2SO4 was studied by incubating an aliquot of the extract with 0.3 ml of normal serum in sufficient Ringer's-bicarbonate for a total volume of 2.3 ml. After 30 min the 15% Na2SO4-insoluble proteins were precipitated with an equal volume (2.3 ml) of 30%o Na2SO4 (w/v), and the quantity of '7CoB,2 coprecipitated was determined by assaying the radioactivity of the supernate.
The solubility of NHGJ-'CoB,2 at 15% Na2SO4 prior to the in vivo incubation was similarly studied. The purpose of the normal serum in these experiments was to increase the total protein concentration of the incubation mixtures in order to facilitate the precipitation of proteins at this salt concentration. Since gamma globulin is also insoluble at 15% Na2SO4, the coprecipitation of "7CoB, after NHGJ-'7CoB,2 is incubated with anti-IF antiserum is due to the binding of the IF-57CoB,2 complex by the immune globulin (18) . To preclude the transfer of any free '7CoB,2 to serum binding proteins, the normal serum and anti-IF antiserum used for all experiments were saturated with 4 ng per ml of crystalline B,2 and the excess unbound B,2 removed with powdered albumin-coated charcoal (300 mg/ml) (20) .
The in vitro interaction between NHGJ-'CoBl2 and extracts of ileal mucosa, isolated brush border membranes, and jejunal mucosa was studied by incubating 25 pg of the gastric juice-bound '7CoBa, with 0.5 ml of each extract in sufficient Ringer's-bicarbonate for a total of 2.0 ml. After 30 min 0.3 ml of normal serum, and an equal volume of 30% Na2SO4 (2.3 ml) was added and the 2 Size of glass beads ranged from 0.012 to 0.11 mm.
percentage of 'CoB,2 precipitated was determined by assaying the radioactivity of the supernate. By appropriately changing the conditions of the reaction mixture the effect of different hydrogen ion concentrations and temperature on the in vitro interaction between NHGJ-7CoB,2 and the ileal extract was investigated. The effect of a chelating agent on this interaction was also studied by substituting either sodium or calcium EDTA for the Ringer's-bicarbonate in the reaction mixture.
Labeled extract was subjected to starch gel electrophoresis as described by Smithies (21) When the peaks of radioactivity were identified, they were eluted by freezing and thawing the gel followed by the application of gentle pressure with a spatula. The eluate from each of the two peaks was incubated separately with 0.3 ml of normal serum and 0.3 ml of anti-IF antiserum, and the fraction of radioactivity contained in the 15% Na2SO4-insoluble fraction was determined as described previously.
The filtration of unlabeled extract through Sephadex gel columns was also studied. Sephadex G-100 and G-200 were equilibrated with distilled water for 24 hr and columns of each, 20-25 cm in height, were prepared by gravity packing followed by washing with 0.9% NaCl. The void and excluded volumes were determined with dextran-blue, and the inner volumes by copper sulfate filtration. A 1 ml aliquot from a pool of six unlabeled ileal extracts was then applied to each of the two columns and filtered with 0.9%o NaCl. The fractions constituting the excluded and inner volumes, respectively, were combined, dialyzed overnight at 4VC against distilled water, and then concentrated in the dialysis bag by fan evaporation to approximately 1 ml. A 0.5 ml aliquot of each concentrated fraction was incubated with 25 pg of NHGJ-7CoBnz in Ringer's-bicarbonate (total volume of 2.0 ml) for 30 min followed by the addition of 0.3 ml of normal serum and an equal volume of 30% Na2SO4. The "7CoB,2 remaining in the supernatant solution was then assayed.
RESULTS
Precipitation of free NHGJ-57CoB12, labeled ileal extract, and mixtures of unlabeled extracts and NHGJ-57CoB,2 at 15%o Na2SO
The data summarized in Table I show that when NHGJ-57CoB12 was incubated with normal serum in Ringer's-bicarbonate and then subjected to a 15% concentration of Na2SO., virtually no radioactivity coprecipitated with the insoluble proteins. However, after the NHGJ-57CoB12 was incubated in vivo in the guinea pig ileum, 56% of the bound 57CoB,2 in the mucosal extract then coprecipitated at this salt concentration, indicating that vitamin B12 bound to NHGJ underwent some change in solubility property during incubation in the ileum. Most of the 57CoB12 in the gastric juice used for the in vivo incubation was bound to IF since 69.5%o of the radioactivity precipitated at 15%o Na2SO, after incubation with anti-IF antiserum.
To investigate whether a similar change in solubility characteristics of NHGJ-bound 57CoB12 occurred in vitro, extracts of ileum, brush border membranes, and jejunum were incubated with NHGJ-57CoB,2 and then subjected to a 15%o concentration of NaSO4 after the addition of normal serum as carrier protein. The data in Table II show that following such incubation with ileal extract, 48.1%o of the radioactivity coprecipitated, while only 3.7%o coprecipitated when the same NHGJ-57CoBl2 was incubated with an extract of jejunum. Thus, it is apparent that the factor responsible for a change in the solubility characteristics of NHGJ-57CoB12 was contained in ileal but not jejunal extracts.
The interaction between the 57CoB12 and this ileal factor appears to require NHGJ because very little free 57CoB12 incubated with ileal extract coprecipitated at 15%o Na2SO4 (Table II, experi- border-poor mucosa, the protein content4 of the brush border membrane extract (0.8 mg/ml) was approximately 1/12 that of the brush border-poor extract (10 mg/ml). Therefore, when considered in terms of specific activity there appears to be considerably more of this ileal factor on the brush borders than in the rest of the ileal mucosal cell.
To study the solubility properties of this ileal factor, anhydrous Na2SO4 was added directly to the ileal extract (150 mg/ml). The resulting precipitate was redissolved in Ringer's-bicarbonate and both the supernate and redissolved precipitate were dialyzed against this solution overnight at 4°C. An aliquot of each fraction was then incubated with NHGJ-57CoB12 as described previously for untreated ileal extract. Table III summarizes the results of this experiment. The ileal factor that reacts with NHGJ-57CoB12 was found primarily in the redissolved precipitate, which indicates that this factor is itself insoluble at 15% Na2SO4.
The data summarized in Table IV indicate that the interaction between NHGJ-57CoB12 and the factor in the ileal extract was inhibited at low pH and low temperature. Preheating the extract at 56°C for 30 min also significantly decreased the radioactivity which coprecipitated at 15% Na2SO4. 4Determined by the biuret method.
The effect of EDTA on the interaction of NHGJ-57CoB,2 and the ileal factor was also investigated, and the results of these experiments are shown in Table V . Sodium EDTA but not calcium EDTA inhibited completely the interaction between NHGJ-57CoB12 and the ileal factor. The IF-B12 complex itself was not affected by the sodium EDTA since 64.1%o of the radioactivity coprecipitated at 15%o Na2SO4 when the NHGJ-57CoB12 was incubated with anti-IF antiserm (experiment 3).
Experiments 4 and 5 of Table V show that when labeled extracts (prepared by in vivo incubation with NHGJ-57CoB,2) were incubated with sodium EDTA only 4%o of the radioactivity coprecipitated at 15%o Na2SO4 yet 72.4%o of the radioactivity of these very same extracts did coprecipitate at this salt concentration when Ringer's-bicarbonate was substituted for the EDTA. It is thus apparent that the in vivo interaction between NHGJ-57CoB12 and the ileal factor could be reversed in vitro by this chelating agent. Fig. 1 A illustrates the radioelectrophoretogram of labeled ileal extract subjecte(l to electrophoresis in gel prepared in borate buffer. There were two major areas of radioactivity, one remaining at the origin (peak A) and one moving anodally (peak B).
The small cathodal peak was free 57CoB12. As shown in Fig. 1 A, (22), immunologically intact IF present in the ileal extract moves in two fractions with different electrophoretic mobilities. Even though the extract prior to electrophoresis contained a significant fraction of radioactivity insoluble at 15% Na2SO1, this fraction could not be positively identified after electrophoresis. The most likely explanation for this is that the Ca++ from the extract moved to the cathode during electrophoresis and this resulted in dissociation of the IF_57CoB,2 from the ileal binding factor. The smaller free IF-57CoB12 then moved anodally more rapidly, while the larger complex lagged behind probably because the dissociation occurred at a slow rate. Although an attempt was made to add calcium to the gel when it was prepared, the calcium precipitated in the cold and satisfactory electrophoretic patterns could not be obtained. Fig. 1 B illustrates the electrophoretic pattern when the same labeled extract was run in gel prepared in Tris-EDTA-borate. A greater percentage of the total radioactivity now moved anodally compared to the pattern in Fig. 1 A, suggesting that when Ca++ was chelated by the EDTA of the gel buffer the dissociation of IF57CoB,2 from the ileal binding factor occurred at a more rapid rate and more of the smaller, free IF-57CoB12 moved anodally. Fig. 1 C is the electrophoretogram obtained when the same labeled extract was incubated with anti-IF antiserum prior to electrophoresis in gel prepared with Tris-EDTA-borate. Most of the radioactivity remained at the origin with gamma globulin, again indicating that the 57CoB12 extracted from the ileum after incubation with NHGJ-57CoB,2 is for the most part bound to IF.
This method of immunologically identifying IF was described by Jeffries, Sleisenger, and Benjamin (23) . Sephadex gel filtraton of unlabeled extract Information regarding molecular size of this ileal binding factor was obtained by filtering an aliquot of pooled, unlabeled ileal extract through G-100 and G-200 Sephadex and reacting the concentrated filtered fractions with NHGJ-57CoB12.
As shown in Table VI this factor was found in the excluded fractions of G-100 indicating that its molecular weight is probably over 100,000. Since shape as well as size influence gel filtration, particularly through G-200 Sephadex, it is tenuous to assume a molecular weight over 200,000 even though most of the factor also appeared in the excluded volume of this gel size.
Kinetic studies of the interaction between NHGJ-57CoB12 and the ileal extract
The velocity of the reaction between the ileal binding factor and NHGJ-57CoB12 is shown in Fig. 2 A. When 25 pg of NHGJ-57CoB12 was incubated with 0.5 ml of ileal extract the increase in the amount of 57CoB12 which precipitated at 15% Na2SO4 was linear for approximately 30 min. This is a rather slow reaction rate when compared to the almost instantaneous reaction between IF and B12. When a fixed quantity of ileal extract was incubated with an increasing quantity of NHGJ57CoB12, the reacting sites of the ileal binding factor could be saturated, as shown in Fig. 2 B. Because this curve resembled the classical Michaelis-Menten (24) plot for enzyme-substrate interactions, the same data was analyzed by the double reciprocal Lineweaver-Burk method (25) and the result is illustrated in Fig. 2 C. From this graph the Km for NHGJ-B12 binding by the ileal factor was calculated to be 5.5 X 1010 M. It would appear from this study that the reaction between this factor and IF-B12 involves association and 51 DISCUSSION The results of the studies presented in this report indicate that a macromolecular factor which binds human intrinsic factor can be extracted from the distal ileum and not the jejunum of the guinea pig. Although the exact nature of this substance has not been defined, it is most probably a protein of rather high molecular weight since it is nondialyzable, is excluded from G-200 Sephadex gel, is precipitated at 15% Na2SO4, and is heat-and acid-labile.
The evidence that this ileal factor is a binder of IF and not B12 alone are the results of the experiments which demonstrated that immunologically intact IF was identified in fractions of ileal extract with different solubility and electrophoretic properties after the intact ileum was incubated with NHGJ-bound vitamin B1,. Additional support for this is the observation that the in vitro interaction between NHGJ-57CoB12 and the ileal extract could be competitively inhibited by an excess of B12-free NHGJ.
Some of the properties observed for this IFbinding factor would account for the conditions which influence the absorption of B12 described previously by other investigators. It is well established that chelation of calcium by EDTA inhibits IF activity in vitro (8, 9, 12) and in vivo (26, 27) . The inhibition of the formation of a complex between the ileal extract and NHGJ-57CoB,2 by sodium EDTA and its reversal by calcium EDTA are consistent with these observations (Table V) . The inhibitory effect of low temperature (5, 9) and low pH (12) on the in vitro activity of IF are similar to the results of the experiments described in this report which demonstrate that these conditions inhibited the binding of IF57CoB12 by the ileal extract (Table IV) .
The identification of the IF-binding factor in extracts of isolated brush border membranes suggests that it may be localized to this site of the epithelial cell, particularly since much more binding factor was found per mg of protein in the border membrane extract than in the extract of the brush border-poor mucosa. Such a localization of this binding factor is consistent with the observations of Donaldson, Mackenzie, and Trier (28) that human gastric juice enhanced the uptake of B12 to epithelial cell brush borders and microvillous membranes of the distal small intestine of the hamster. Mackenzie, Kopp, Donaldson, and Trier (29) recently reported that antiserum produced against isolated brush border preparations inhibited the uptake of vitamin B1,. If the primary location of this ileal binding factor is on this site of the mucosal cell, the antibody-induced impaired B12 absorption may very well have been due to specific antibody inactivation of this factor.
Hansen and Miller (30) reported in an abstract that RNA competitively inhibited the binding of IF-B12 to zirconyl phosphate gel and suggested that this nucleic acid may be a cofactor requirement for vitamin B12 absorption. Although it is possible that the ileal IF-binding factor described in this report may be RNA or an RNA nucleoprotein, its stability at pH 10 (Table IV) where both RNA and RNA protein are generally unstable makes this contention unlikely. However, more definite conclusions concerning the exact chemical nature of this ileal protein must await its purification.
Cooper (14) has studied the uptake of B12 by everted sacs of guinea pig intestine and also found Michaelis-Menten kinetics when saturating quantities of NHGJ-B12 were used. It is interesting that he obtained a Km value for B12 uptake by the intestinal sac of 6.8 X 10-1 M which is within close agreement to the 5.5 x 10-1o M value obtained in this study. However, it is now more apparent that these constants really reflect not B12 uptake by intestine or intestinal extracts but rather the binding of the IF-B12 complex by this ileal binding factor (or perhaps more appropriately termed ileal intrinsic factor). The importance of the B12 molecule in this reaction must still be studied. Although a 120-fold excess of NHGJ did competitively inhibit the binding of NHGJ-B12 by the ileal extract (Table II) , Cooper (14) has reported that a four fold excess of free NHGJ did not compete as effectively as NHGJ-B12 for the receptor sites of guinea pig ileum. A more precise investigation into the kinetics of the reaction between this ileal factor, NHGJ-B12, and B12-free NHGJ will also require a more purified preparation of this macromolecule.
Although direct extrapolation of the results of animal experiments to explain human biologic phenomena may well be questioned, the results of the experiments described in this report indicate that an IF-binding factor is probably also present in human ileum for two principle reasons. First, it has been shown that the IF-enhanced absorption of B12 in guinea pig ileum can be mediated by many sources of animal IF (31) which suggests that this is a fundamental mechanism common to all mammalian species. Secondly, and more specifically, it has been shown that human IF enhances the absorption of B12 by guinea pig ileum (9) . Since, for obvious reasons, it was not possible to use normal human ileum, the combination of NHGJ and guinea pig ileum, therefore, appeared to be most appropriate.
Recently, Frentz, Miller, and Hansen (32) reported in an abstract that 4 hr after the administration of IF-B1t to the rat, the soluble radioactivity of the intestinal homogenate was associated with two binding proteins, one of molecular size comparable to IF-B12 (50,000-60,000) and a second with a mol wt greater than 100,000. Although they did not report further identification of these B,2-protein complexes, it seems probable from the guinea pig experiments described in this report that one complex was IF-B12 and the second may have been IF-B12 bound to the ileal binding factor. These observations in the rat as well as the results of our experiments with guinea pig ileal extracts, support the premise that IF binding by an ileal protein is a fundamental mechanism of B. 2 absorption, probably common to all mammalians.
As the mechanism for vitamin B12 absorption unfolds, it clearly involves the formation of at least two intermolecular complexes, each serving a specific function. The formation of the IF-B12 complex is probably an evolutionary development to protect the vitamin from intestinal microbial degradation, since several bacteria including forms of Aerobacter (33) and Pseudomonas (34) are known to convert B12 to other pigments. The protective effect of IF binding is also known since the original observations of Ternberg and Eakin (2) demonstrated that binding of B12 to gastric juice rendered it unavailable as a growth promoting factor for microorganisms.
Once the vitamin has been transported to the site of absorption in the distal ileum, the large size of the B12 molecule prevents passive diffusion and necessitates a time consuming absorptive process which the rate of intestinal flow in this area would preclude. Accordingly, a second intermolecular complex forms in which IF with its attached B12 moiety binds to an ileal intrinsic factor thus preventing its loss into the lumen of the colon. Although this speculative role of the ileal binding factor as an anchor for the IF-B12 complex may not be consistent with the relatively slow rate of in vitro interaction of these two factors found in these studies, the higher concentration of IF-B12 in intestinal succus and an in vivo milieu may result in a significantly more rapid rate of binding of the IF-B12 complex.
Another question which must ultimately be answered is whether, in addition to this speculative role as an anchor for IF-B12, the ileal binding factor facilitates the entry of B12 into and through the mucosal cell. We are now studying methods of separating more precisely the cellular constituents of the intestinal mucosa using density gradient centrifugation. If it can be shown that this IFbinding factor is present in the extract of mucosa completely free of brush border contamination, it would indicate that it serves more than just a passive IF-binding role, and participates actively as a carrier of the IF-B12 complex from cell surface to cell cytoplasm.
